These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11378514)

  • 21. Long-term production of BDNF and NT-3 induced by A91-immunization after spinal cord injury.
    Martiñón S; García-Vences E; Toscano-Tejeida D; Flores-Romero A; Rodriguez-Barrera R; Ferrusquia M; Hernández-Muñoz RE; Ibarra A
    BMC Neurosci; 2016 Jun; 17(1):42. PubMed ID: 27364353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymer and nano-technology applications for repair and reconstruction of the central nervous system.
    Cho Y; Borgens RB
    Exp Neurol; 2012 Jan; 233(1):126-44. PubMed ID: 21985867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seeking axon guidance molecules in the adult rat CNS.
    Doucet G; Petit A
    Prog Brain Res; 2002; 137():453-65. PubMed ID: 12440387
    [No Abstract]   [Full Text] [Related]  

  • 24. Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift.
    Schwartz M; Kipnis J
    Neuroscientist; 2002 Oct; 8(5):405-13. PubMed ID: 12374425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion.
    Hauben E; Butovsky O; Nevo U; Yoles E; Moalem G; Agranov E; Mor F; Leibowitz-Amit R; Pevsner E; Akselrod S; Neeman M; Cohen IR; Schwartz M
    J Neurosci; 2000 Sep; 20(17):6421-30. PubMed ID: 10964948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiological approaches to neuroprotection. boosting of protective autoimmunity.
    Schwartz M
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S256-60; discussion S273-6. PubMed ID: 11377445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune maintenance and neuroprotection of the central nervous system.
    Cohen IR; Schwartz M
    J Neuroimmunol; 1999 Dec; 100(1-2):111-4. PubMed ID: 10695721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy strategies for spinal cord injury.
    Wang YT; Lu XM; Chen KT; Shu YH; Qiu CH
    Curr Pharm Biotechnol; 2015; 16(6):492-505. PubMed ID: 25860061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helping The Body To Cure Itself: Immune Modulation By Therapeutic Vaccination For Spinal Cord Injury.
    Schwartz M
    J Spinal Cord Med; 2003 Jan; 26(sup1):S6-S10. PubMed ID: 27700258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model.
    Kwidzinski E; Mutlu LK; Kovac AD; Bunse J; Goldmann J; Mahlo J; Aktas O; Zipp F; Kamradt T; Nitsch R; Bechmann I
    J Neural Transm Suppl; 2003; (65):29-49. PubMed ID: 12946047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effect of vaccination with autoantigen-pulsed dendritic cells after spinal cord injury.
    Wang Y; Wang K; Chao R; Li J; Zhou L; Ma J; Yan J
    J Surg Res; 2012 Jul; 176(1):281-92. PubMed ID: 21872882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma.
    Schori H; Kipnis J; Yoles E; WoldeMussie E; Ruiz G; Wheeler LA; Schwartz M
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3398-403. PubMed ID: 11248090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic T cell-based vaccination for neurodegenerative disorders: the role of CD4+CD25+ regulatory T cells.
    Schwartz M; Kipnis J
    Ann N Y Acad Sci; 2005 Jun; 1051():701-8. PubMed ID: 16127010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Conservative treatment of central nervous system injuries. II. Closed skull injuries: treatment of blood volume and composition disorders, disorders of the aicd-base equilibrium, post-traumatic brain edema. Conservative treatment of spinal cord injury].
    Vladyka V
    Cesk Neurol; 1971 Nov; 34(6):315-24. PubMed ID: 5121716
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury.
    Hauben E; Gothilf A; Cohen A; Butovsky O; Nevo U; Smirnov I; Yoles E; Akselrod S; Schwartz M
    J Neurosci; 2003 Sep; 23(25):8808-19. PubMed ID: 14507981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological approaches to the treatment of spinal cord injury.
    Schwartz M
    BioDrugs; 2001; 15(9):585-93. PubMed ID: 11580302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats.
    Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Zeng L; Long ZY; Wu YM
    Biomaterials; 2011 Nov; 32(31):7988-98. PubMed ID: 21784510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats.
    Ibarra A; Hauben E; Butovsky O; Schwartz M
    Eur J Neurosci; 2004 Jun; 19(11):2984-90. PubMed ID: 15182305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Wnt Signaling in Central Nervous System Injury.
    Lambert C; Cisternas P; Inestrosa NC
    Mol Neurobiol; 2016 May; 53(4):2297-311. PubMed ID: 25976365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy.
    Moalem G; Leibowitz-Amit R; Yoles E; Mor F; Cohen IR; Schwartz M
    Nat Med; 1999 Jan; 5(1):49-55. PubMed ID: 9883839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.